{"id":"W2750756186","doi":"10.1093/brain/awx185","title":"Towards personalized therapy for multiple sclerosis: prediction of individual treatment response","year":2017,"lang":"en","type":"article","venue":"Brain","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; Sanofi Genzyme; Novartis Pharma; EMD Serono; H. Lundbeck A/S; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Fondazione Italiana Sclerosi Multipla; Medical Research Council; Biogen; Sanofi","keywords":"Natalizumab; Fingolimod; Medicine; Cohort; Discontinuation; Disease; Multiple sclerosis; External validity; Proportional hazards model; Cohort study; Physical therapy; Clinical trial; Internal medicine; Oncology; Psychology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001007649,0.0001565582,0.0003667765,0.0001085231,0.0003672931,0.00004590519,0.0001900646,0.00008143346,0.00005760544],"category_scores_gemma":[0.0042028,0.0001146477,0.0002142738,0.00004260075,0.0003006175,0.0000904093,0.00006730955,0.00006433804,0.000004453575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001168076,"about_ca_system_score_gemma":0.0001963039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001398394,"about_ca_topic_score_gemma":0.00002399294,"domain_scores_codex":[0.9986449,0.0001252582,0.0002328275,0.000271009,0.0004495025,0.0002764781],"domain_scores_gemma":[0.9984504,0.0005593799,0.0001481052,0.0005434164,0.0001809127,0.0001177804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0378225,0.001244966,0.07474513,0.0001033164,0.001281329,0.000005240171,0.00783843,0.000001845837,0.4879557,0.00006188975,0.02135859,0.3675811],"study_design_scores_gemma":[0.019188,0.002534251,0.9095393,0.0001338006,0.00003308797,0.000001920307,0.0004111582,0.000312307,0.03460818,0.00001657329,0.03314646,0.00007495074],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869386,0.0005365854,0.0001719686,0.009348483,0.0001035576,0.001790712,0.0008093594,0.00005039855,0.0002503547],"genre_scores_gemma":[0.9947137,0.0009374669,0.002032802,0.0001896338,0.0001955736,0.0005949749,0.00005709899,0.00002586411,0.001252887],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8347942,"threshold_uncertainty_score":0.5031447,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2307511624584449,"score_gpt":0.3812508765157432,"score_spread":0.1504997140572983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}